Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

iPS cells can support full-term development of tetraploid blastocyst-complemented embryos.

Kang L, Wang J, Zhang Y, Kou Z, Gao S.

Cell Stem Cell. 2009 Aug 7;5(2):135-8. doi: 10.1016/j.stem.2009.07.001. Epub 2009 Jul 23. No abstract available.

2.

c-MYC independent nuclear reprogramming favors cardiogenic potential of induced pluripotent stem cells.

Martinez-Fernandez A, Nelson TJ, Ikeda Y, Terzic A.

J Cardiovasc Transl Res. 2010 Feb;3(1):13-23. doi: 10.1007/s12265-009-9150-5.

3.

Sequential addition of reprogramming factors improves efficiency.

Gaeta X, Xie Y, Lowry WE.

Nat Cell Biol. 2013 Jul;15(7):725-7. doi: 10.1038/ncb2800.

PMID:
23817236
4.

Reprogramming adipose tissue-derived mesenchymal stem cells into pluripotent stem cells by a mutant adeno-associated viral vector.

Chen MJ, Lu Y, Hamazaki T, Tsai HY, Erger K, Conlon T, Elshikha AS, Li H, Srivastava A, Yao C, Brantly M, Chiodo V, Hauswirth W, Terada N, Song S.

Hum Gene Ther Methods. 2014 Feb;25(1):72-82. doi: 10.1089/hgtb.2013.011. Epub 2013 Dec 28.

5.

iPS programmed without c-MYC yield proficient cardiogenesis for functional heart chimerism.

Martinez-Fernandez A, Nelson TJ, Yamada S, Reyes S, Alekseev AE, Perez-Terzic C, Ikeda Y, Terzic A.

Circ Res. 2009 Sep 25;105(7):648-56. doi: 10.1161/CIRCRESAHA.109.203109. Epub 2009 Aug 20.

6.

c-Myc is dispensable for direct reprogramming of mouse fibroblasts.

Wernig M, Meissner A, Cassady JP, Jaenisch R.

Cell Stem Cell. 2008 Jan 10;2(1):10-2. doi: 10.1016/j.stem.2007.12.001. Epub 2007 Dec 13. No abstract available.

7.

Excision of reprogramming transgenes improves the differentiation potential of iPS cells generated with a single excisable vector.

Sommer CA, Sommer AG, Longmire TA, Christodoulou C, Thomas DD, Gostissa M, Alt FW, Murphy GJ, Kotton DN, Mostoslavsky G.

Stem Cells. 2010 Jan;28(1):64-74. doi: 10.1002/stem.255.

8.

Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors.

Kim JB, Zaehres H, Wu G, Gentile L, Ko K, Sebastiano V, Araúzo-Bravo MJ, Ruau D, Han DW, Zenke M, Schöler HR.

Nature. 2008 Jul 31;454(7204):646-50. doi: 10.1038/nature07061. Epub 2008 Jun 29.

PMID:
18594515
9.
10.

Literature Watch: implications for transplantation.

Muller YD, Meier RP, Bromberg JS, Bühler LH.

Am J Transplant. 2013 Jun;13(6):1377. doi: 10.1111/ajt.12322. No abstract available.

11.

An astonishing experiment.

Wilmut I.

Cloning Stem Cells. 2006 Winter;8(4):235-6. No abstract available.

PMID:
17196087
12.

Induced pluripotency and cellular alchemy.

Perry AC.

Nat Biotechnol. 2006 Nov;24(11):1363-4. No abstract available.

PMID:
17093483
13.

Proliferation rate of somatic cells affects reprogramming efficiency.

Xu Y, Wei X, Wang M, Zhang R, Fu Y, Xing M, Hua Q, Xie X.

J Biol Chem. 2013 Apr 5;288(14):9767-78. doi: 10.1074/jbc.M112.403881. Epub 2013 Feb 25.

14.

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

Takahashi K, Yamanaka S.

Cell. 2006 Aug 25;126(4):663-76. Epub 2006 Aug 10.

15.

Muse cells and induced pluripotent stem cell: implication of the elite model.

Kitada M, Wakao S, Dezawa M.

Cell Mol Life Sci. 2012 Nov;69(22):3739-50. doi: 10.1007/s00018-012-0994-5. Epub 2012 Apr 24. Review.

16.

Characterization of bovine induced pluripotent stem cells by lentiviral transduction of reprogramming factor fusion proteins.

Cao H, Yang P, Pu Y, Sun X, Yin H, Zhang Y, Zhang Y, Li Y, Liu Y, Fang F, Zhang Z, Tao Y, Zhang X.

Int J Biol Sci. 2012;8(4):498-511. doi: 10.7150/ijbs.3723. Epub 2012 Mar 21.

17.

On the road to iPS cell cardiovascular applications.

Kamp TJ, Lyons GE.

Circ Res. 2009 Sep 25;105(7):617-9. doi: 10.1161/CIRCRESAHA.109.205740. No abstract available.

18.

Transgenic mice with defined combinations of drug-inducible reprogramming factors.

Markoulaki S, Hanna J, Beard C, Carey BW, Cheng AW, Lengner CJ, Dausman JA, Fu D, Gao Q, Wu S, Cassady JP, Jaenisch R.

Nat Biotechnol. 2009 Feb;27(2):169-71. doi: 10.1038/nbt.1520. Epub 2009 Jan 18.

19.

Enhanced efficiency of generating induced pluripotent stem (iPS) cells from human somatic cells by a combination of six transcription factors.

Liao J, Wu Z, Wang Y, Cheng L, Cui C, Gao Y, Chen T, Rao L, Chen S, Jia N, Dai H, Xin S, Kang J, Pei G, Xiao L.

Cell Res. 2008 May;18(5):600-3. doi: 10.1038/cr.2008.51. No abstract available.

20.

[Induction and characterization of induced pluripotent stem (iPS) cells: a review].

Cheng D, Lei L, Lu Z, Li Z, Wang H.

Sheng Wu Gong Cheng Xue Bao. 2010 Apr;26(4):421-30. Review. Chinese.

PMID:
20575428
Items per page

Supplemental Content

Write to the Help Desk